| Date Filed | Type | Description |
| 08/25/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 76,969 shares
@ $1.53, valued at
$117.8k
Exercised 141,587 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 55,855 shares
@ $1.66, valued at
$92.7k
Exercised 141,587 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 41,436 shares
@ $1.44, valued at
$59.7k
Exercised 141,587 restricted stock units
@ $0 |
|
| 08/04/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 52,870 shares
@ $1.1, valued at
$58.2k
Exercised 141,587 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Granted 1,732,300 options to buy
@ $1.21, valued at
$2.1M
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Bought 22,857 shares
@ $1.75, valued at
$40k
|
|
| 01/06/2023 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Exercised 17,665 restricted stock units
@ $0 |
|
| 06/15/2022 |
4
| Sabzevari Helen (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Granted 847,000 options to buy
@ $2.33, valued at
$2M
|
|
| 01/06/2022 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 1,357 shares
@ $3.59, valued at
$4.9k
Sold 5,603 shares
@ $3.5901, valued at
$20.1k
Exercised 17,667 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 3,848 shares
@ $3.6701, valued at
$14.1k
Exercised 9,765 restricted stock units
@ $0 |
|
| 07/20/2021 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 12,531 shares
@ $5.4303, valued at
$68k
Exercised 25,000 restricted stock units
@ $0 |
|
| 06/28/2021 |
4
| Sabzevari Helen (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 40,501 options to buy
@ $24.38, valued at
$987.4k
|
|
| 06/28/2021 |
3
| Sabzevari Helen (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 12,220 shares
@ $4.58, valued at
$56k
Exercised 25,000 restricted stock units
@ $0 |
|
| 05/18/2020 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 217,527 shares
@ $2.3712, valued at
$515.8k
Exercised 500,000 restricted stock units
@ $0 |
|
| 04/02/2020 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Sold 5,450 shares
@ $3.0119, valued at
$16.4k
Exercised 14,340 restricted stock units
@ $0 |
|
| 03/23/2020 |
4
| Sabzevari Helen (President and CEO) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Granted 500,000 restricted stock units
@ $0 |
|
| 01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2019 |
4
| Sabzevari Helen (President, Precigen, Inc.) has filed a Form 4 on INTREXON CORP|
Txns:
| Sold 8,484 shares
@ $7.4702, valued at
$63.4k
Exercised 25,000 restricted stock units
@ $0 |
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2019 |
4
| Sabzevari Helen (President, Precigen, Inc.) has filed a Form 4 on INTREXON CORP|
Txns:
| Granted 57,362 restricted stock units
@ $0 |
|
| 01/29/2019 |
4
| Sabzevari Helen (President, Precigen, Inc.) has filed a Form 4 on INTREXON CORP|
Txns:
| Granted 56,891 restricted stock units
@ $0 |
|
|